Cerus (CERS) Competitors $1.68 +0.08 (+5.00%) Closing price 10/8/2025 04:00 PM EasternExtended Trading$1.72 +0.04 (+2.08%) As of 10/8/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CERS vs. OSUR, UTMD, ANIK, WST, COO, ALGN, MMSI, ICUI, XRAY, and HAEShould you be buying Cerus stock or one of its competitors? The main competitors of Cerus include OraSure Technologies (OSUR), Utah Medical Products (UTMD), Anika Therapeutics (ANIK), West Pharmaceutical Services (WST), Cooper Companies (COO), Align Technology (ALGN), Merit Medical Systems (MMSI), ICU Medical (ICUI), DENTSPLY SIRONA (XRAY), and Haemonetics (HAE). These companies are all part of the "health care supplies" industry. Cerus vs. Its Competitors OraSure Technologies Utah Medical Products Anika Therapeutics West Pharmaceutical Services Cooper Companies Align Technology Merit Medical Systems ICU Medical DENTSPLY SIRONA Haemonetics OraSure Technologies (NASDAQ:OSUR) and Cerus (NASDAQ:CERS) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, profitability, institutional ownership, media sentiment, analyst recommendations, valuation and risk. Which has more volatility and risk, OSUR or CERS? OraSure Technologies has a beta of 0.46, indicating that its stock price is 54% less volatile than the S&P 500. Comparatively, Cerus has a beta of 1.7, indicating that its stock price is 70% more volatile than the S&P 500. Does the media refer more to OSUR or CERS? In the previous week, OraSure Technologies and OraSure Technologies both had 3 articles in the media. Cerus' average media sentiment score of 1.53 beat OraSure Technologies' score of 1.18 indicating that Cerus is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment OraSure Technologies 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cerus 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Which has better earnings & valuation, OSUR or CERS? OraSure Technologies has higher earnings, but lower revenue than Cerus. Cerus is trading at a lower price-to-earnings ratio than OraSure Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOraSure Technologies$185.83M1.28-$19.50M-$0.67-4.84Cerus$192.51M1.67-$20.92M-$0.10-16.80 Is OSUR or CERS more profitable? Cerus has a net margin of -9.81% compared to OraSure Technologies' net margin of -36.84%. OraSure Technologies' return on equity of -10.81% beat Cerus' return on equity.Company Net Margins Return on Equity Return on Assets OraSure Technologies-36.84% -10.81% -9.44% Cerus -9.81%-33.77%-9.32% Do analysts prefer OSUR or CERS? OraSure Technologies presently has a consensus price target of $3.00, indicating a potential downside of 7.41%. Cerus has a consensus price target of $3.50, indicating a potential upside of 108.33%. Given Cerus' stronger consensus rating and higher possible upside, analysts plainly believe Cerus is more favorable than OraSure Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score OraSure Technologies 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50Cerus 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33 Do insiders and institutionals believe in OSUR or CERS? 93.5% of OraSure Technologies shares are held by institutional investors. Comparatively, 78.4% of Cerus shares are held by institutional investors. 3.9% of OraSure Technologies shares are held by company insiders. Comparatively, 5.6% of Cerus shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. SummaryCerus beats OraSure Technologies on 11 of the 15 factors compared between the two stocks. Get Cerus News Delivered to You Automatically Sign up to receive the latest news and ratings for CERS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CERS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CERS vs. The Competition Export to ExcelMetricCerusMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$306.72M$10.66B$6.11B$10.56BDividend YieldN/A1.87%5.69%4.75%P/E Ratio-16.8021.8785.4827.60Price / Sales1.6732.53616.90236.99Price / CashN/A25.4637.9261.55Price / Book5.423.4513.136.76Net Income-$20.92M$208.83M$3.30B$275.88M7 Day Performance11.26%1.63%4.29%2.81%1 Month Performance30.23%2.06%9.45%9.24%1 Year Performance-10.16%-5.12%86.64%35.42% Cerus Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CERSCerus2.3658 of 5 stars$1.68+5.0%$3.50+108.3%-2.3%$306.72M$192.51M-16.80290Positive NewsAnalyst ForecastShort Interest ↑OSUROraSure Technologies1.9117 of 5 stars$3.18-0.6%$3.00-5.7%-20.8%$234.04M$185.83M-4.75840News CoveragePositive NewsAnalyst ForecastUTMDUtah Medical Products2.5905 of 5 stars$62.72-0.1%N/A-2.5%$201.35M$40.90M16.77180News CoverageAnalyst ForecastANIKAnika Therapeutics4.2385 of 5 stars$9.14+1.3%$18.00+96.9%-62.5%$130.05M$119.91M-2.20300News CoverageAnalyst ForecastWSTWest Pharmaceutical Services4.864 of 5 stars$260.04-0.6%$318.56+22.5%-6.5%$18.81B$2.89B38.9310,600Analyst ForecastCOOCooper Companies4.0187 of 5 stars$67.67+0.2%$86.64+28.0%-33.5%$13.43B$3.90B33.3416,000Analyst ForecastALGNAlign Technology4.8509 of 5 stars$126.37+0.1%$215.00+70.1%-43.1%$9.15B$4.00B21.3120,945Analyst ForecastMMSIMerit Medical Systems4.6929 of 5 stars$80.86+0.8%$107.50+32.9%-12.5%$4.75B$1.36B41.057,400Analyst ForecastICUIICU Medical4.4577 of 5 stars$117.04-1.5%$181.00+54.6%-32.5%$2.93B$2.38B-77.0015,000Analyst ForecastXRAYDENTSPLY SIRONA4.8844 of 5 stars$12.61+0.9%$18.64+47.8%-49.4%$2.49B$3.79B-2.6614,000Analyst ForecastHAEHaemonetics4.9358 of 5 stars$48.150.0%$78.78+63.6%-33.5%$2.32B$1.36B14.723,023Trending NewsAnalyst ForecastAnalyst Revision Related Companies and Tools Related Companies OSUR Competitors UTMD Competitors ANIK Competitors WST Competitors COO Competitors ALGN Competitors MMSI Competitors ICUI Competitors XRAY Competitors HAE Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CERS) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cerus Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Cerus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
